Document is current
Any future updates will be listed below
-
Authors
Demek, Erin
Arroyo-Currás, Netzahualcóyotl
-
Funding
Funding for this research was provided by:
Air Force Office of Scientific Research (FA9550-20-1-0117)
Air Force Office of Scientific Research (FA9550-20-1-0117)
- License Information
-
More Information
Article History
Received: 16 July 2025
Accepted: 14 November 2025
First Online: 9 January 2026
Competing interests
: N.A.-C. has filed a patent application related to the emtricitabine aptamer sequence reported in this study, as well as to its application to therapeutic drug monitoring and monitoring of adherence to therapy. E.D. declares no competing interests.
